These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8118925)

  • 1. A mechanistic hypothesis for DNA adduct formation by tamoxifen following hepatic oxidative metabolism.
    Potter GA; McCague R; Jarman M
    Carcinogenesis; 1994 Mar; 15(3):439-42. PubMed ID: 8118925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite.
    Randerath K; Moorthy B; Mabon N; Sriram P
    Carcinogenesis; 1994 Oct; 15(10):2087-94. PubMed ID: 7955037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-Hydroxylated metabolites of the antiestrogens tamoxifen and toremifene are metabolized to unusually stable quinone methides.
    Fan PW; Zhang F; Bolton JL
    Chem Res Toxicol; 2000 Jan; 13(1):45-52. PubMed ID: 10649966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytochrome P-450 3A and 2D6 catalyze ortho hydroxylation of 4-hydroxytamoxifen and 3-hydroxytamoxifen (droloxifene) yielding tamoxifen catechol: involvement of catechols in covalent binding to hepatic proteins.
    Dehal SS; Kupfer D
    Drug Metab Dispos; 1999 Jun; 27(6):681-8. PubMed ID: 10348797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced genotoxicity of [D5-ethyl]-tamoxifen implicates alpha-hydroxylation of the ethyl group as a major pathway of tamoxifen activation to a liver carcinogen.
    Phillips DH; Potter GA; Horton MN; Hewer A; Crofton-Sleigh C; Jarman M; Venitt S
    Carcinogenesis; 1994 Aug; 15(8):1487-92. PubMed ID: 8055624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and reactivity of potential toxic metabolites of tamoxifen analogues: droloxifene and toremifene o-quinones.
    Yao D; Zhang F; Yu L; Yang Y; van Breemen RB; Bolton JL
    Chem Res Toxicol; 2001 Dec; 14(12):1643-53. PubMed ID: 11743747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-demethylation accompanies alpha-hydroxylation in the metabolic activation of tamoxifen in rat liver cells.
    Phillips DH; Hewer A; Horton MN; Cole KJ; Carmichael PL; Davis W; Osborne MR
    Carcinogenesis; 1999 Oct; 20(10):2003-9. PubMed ID: 10506117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tamoxifen metabolic activation: comparison of DNA adducts formed by microsomal and chemical activation of tamoxifen and 4-hydroxytamoxifen with DNA adducts formed in vivo.
    Moorthy B; Sriram P; Pathak DN; Bodell WJ; Randerath K
    Cancer Res; 1996 Jan; 56(1):53-7. PubMed ID: 8548775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA adduct formation in the livers of female Sprague-Dawley rats treated with toremifene or alpha-hydroxytoremifene.
    Gamboa da Costa G; Pereira PC; Churchwell MI; Beland FA; Marques MM
    Chem Res Toxicol; 2007 Feb; 20(2):300-10. PubMed ID: 17261033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-Hydroxytamoxifen, a metabolite of tamoxifen with exceptionally high DNA-binding activity in rat hepatocytes.
    Phillips DH; Carmichael PL; Hewer A; Cole KJ; Poon GK
    Cancer Res; 1994 Nov; 54(21):5518-22. PubMed ID: 7923188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idoxifene derivatives are less reactive to DNA than tamoxifen derivatives, both chemically and in human and rat liver cells.
    Osborne MR; Hewer A; Davis W; Strain AJ; Keogh A; Hardcastle IR; Phillips DH
    Carcinogenesis; 1999 Feb; 20(2):293-7. PubMed ID: 10069467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational studies and electronic structures of tamoxifen and toremifene and their allylic carbocations proposed as reactive intermediates leading to DNA adduct formation.
    Kuramochi H
    J Med Chem; 1996 Jul; 39(15):2877-86. PubMed ID: 8709121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idoxifene is equipotent to tamoxifen in inhibiting mammary carcinogenesis but forms lower levels of hepatic DNA adducts.
    Pace P; Jarman M; Phillips D; Hewer A; Bliss J; Coombes RC
    Br J Cancer; 1997; 76(6):700-4. PubMed ID: 9310233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and investigation of alpha-hydroxy-N,N-didesmethyltamoxifen as a proximate carcinogen in the metabolic activation of tamoxifen.
    Gamboa da Costa G; Marques MM; Freeman JP; Beland FA
    Chem Res Toxicol; 2003 Sep; 16(9):1090-8. PubMed ID: 12971796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The deuterium isotope effect for the alpha-hydroxylation of tamoxifen by rat liver microsomes accounts for the reduced genotoxicity of [D5-ethyl]tamoxifen.
    Jarman M; Poon GK; Rowlands MG; Grimshaw RM; Horton MN; Potter GA; McCague R
    Carcinogenesis; 1995 Apr; 16(4):683-8. PubMed ID: 7728943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of DNA damage in F344 rats induced by geometric isomers of tamoxifen and analogues.
    Brown K; Brown JE; Martin EA; Smith LL; White IN
    Chem Res Toxicol; 1998 May; 11(5):527-34. PubMed ID: 9585484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of N,N-didesmethyltamoxifen upon DNA adduct formation by tamoxifen and alpha-hydroxytamoxifen.
    Gamboa da Costa G; Marques MM; Fu X; Churchwell MI; Wang YP; Doerge DR; Beland FA
    Cancer Lett; 2007 Nov; 257(2):191-8. PubMed ID: 17765393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-chromatography of a tamoxifen epoxide-deoxyguanylic acid adduct with a major DNA adduct formed in the livers of tamoxifen-treated rats.
    Phillips DH; Hewer A; White IN; Farmer PB
    Carcinogenesis; 1994 May; 15(5):793-5. PubMed ID: 8200077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of tamoxifen-4-hydroxylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), beta-naphthoflavone (beta NF), and phenobarbital (PB) in avian liver: identification of P450 TCDDAA as catalyst of 4-hydroxylation induced by TCDD and beta NF.
    Kupfer D; Mani C; Lee CA; Rifkind AB
    Cancer Res; 1994 Jun; 54(12):3140-4. PubMed ID: 8205532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotoxic potential of tamoxifen and analogues in female Fischer F344/n rats, DBA/2 and C57BL/6 mice and in human MCL-5 cells.
    White IN; de Matteis F; Davies A; Smith LL; Crofton-Sleigh C; Venitt S; Hewer A; Phillips DH
    Carcinogenesis; 1992 Dec; 13(12):2197-203. PubMed ID: 1473224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.